Form D · Biotechnology
Deact Medical Solutions Inc
Newark, DE · CIK 0001728846
Offering snapshot reported Jan 22, 2018 · SEC filing
- Reported sold
- $15K Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 8, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 22, 2018 | Initial | $15,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-303781
Rights to receive certain shares of the Issuer's stock subject to terms of Simple Agreement for Future Equity (SAFE).
Source: Form D, filed Jan 22, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Trevor J Brown | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
550 South College Avenue
Newark, DE, 19713
Newark, DE, 19713